Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau

Clinical study on novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau promoted by individualized nutritional assessment and supportive treatment

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030260

Enrollment

Unknown

Registered

2020-02-26

Start date

2020-02-27

Completion date

Unknown

Last updated

2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Experimental group:enteral nutrition emulsion, tpf-t 200ml Bid

Control group:No intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. novel coronavirus pneumonia patients with nutritional malnutrition diagnosed by nutritional assessment; 2. enteral nutrition support treatment for at least 5 days; 3. No use of Fat emulsion taboo;

Exclusion criteria

Exclusion criteria: 1. No malnutrition; 2. Patients who had received antiviral drugs, immunosuppressive drugs and cytotoxic drugs 2 weeks before diagnosis; 3. patients with hypertriglyceridemia (TG): Serum TG > 3.0mmol/l; 4. patients with severe liver and kidney dysfunction; 5. pregnant women; 6.tumor patients.

Design outcomes

Primary

Measure	Time frame
NRS 2002 score;BMI;triceps skinfold thickness (TSF);prealbumin;total albumin;leucocyte count;CRP;lymphocyte percentage;TNF- alpha;IL-6;	—

Countries

China

Contacts

Public ContactLijia Deng

Ganzi Hospital of West China Hospital, Sichuan University

27216302@qq.com+86 17723451376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026